DJ AstraZeneca PLC ADR Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ slipped 1.27% to $69.86 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.20% to 19,391.96 and Dow Jones Industrial Average falling 0.28% to 44,421.91.
This was the ADR's second consecutive day of losses.
AstraZeneca PLC ADR closed 20.32% below its 52-week high of $87.68, which the company reached on August 30th.
The ADR underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ fell 0.08% to $810.43, Biogen Inc. $(BIIB)$ fell 1.10% to $142.34, and Johnson & Johnson $(JNJ)$ fell 0.18% to $151.87.
Trading volume (5.0 M) remained 281,902 below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 03, 2025 17:23 ET (22:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。